Nutriband (NTRB) stock forecast for 2022
Last update: 08-15-2022, 14:18Sector: Healthcare
The share price of Nutriband Inc. (NTRB) now
What analysts predict:: $15.5
52-week high/low: $12.86 / $2.409
50/200 Day Moving Average: $3.832 / $4.116
This figure corresponds to the average price over the previous 50/200 days. For Nutriband stocks, the 50-day moving average is the support level today.
For Nutriband stocks, the 200-day moving average is the support level today.
Are you interested in Nutriband stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nutriband stock price in 2022. How much will one Nutriband share be worth in 2022?
Is it worth taking profit / loss on Nutriband stock now or waiting? What are analysts' forecasts for Nutriband stock?
We forecast Nutriband stock performance using neural networks based on historical data on Nutriband stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Nutriband stock prediction results are shown below and presented as a graph, table and text information.
Nutriband stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Nutriband analysts is $15.5.
Today 200 Day Moving Average is the support level (4.116 $).
50 Day Moving Average is the support level (3.832 $).
Historical and forecast chart of Nutriband stock
The chart below shows the historical price of Nutriband stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Nutriband stock price can be found in the table below.
Nutriband (NTRB) Forecast for 2022
Nutriband information and performance
At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting the Global Opioid epidemic. Fentanyl and other opioid based transdermal medications unfortunately play a role in a significant number of opioid deaths each year with no solution currently available. Working with our Clinical subsidiary 4P Therapeutics we have developed a technology called AVERSA which we believe with FDA approval will revolutionize the safety standard for these medications and save countless lives per year.
309 CELTIC COURT, OVIEDO, FL, US
Market Capitalization: 38 289 700 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -3 991 758 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.103
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 370.37
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 21.21
Enterprise Value (EV) /Revenue
EV To EBITDA: -5.07
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 7751000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Nutriband price target for 2021 by month
Target values for the price of one Nutriband share for Sep 2022.
Pessimistic target level: 4.76
Optimistic target level: 5.42
Target values for the price of one Nutriband share for Oct 2022.
Pessimistic target level: 5.28
Optimistic target level: 6.14
Target values for the price of one Nutriband share for Nov 2022.
Pessimistic target level: 5.06
Optimistic target level: 5.91
Target values for the price of one Nutriband share for Dec 2022.
Pessimistic target level: 4.05
Optimistic target level: 4.55
Nutriband (NTRB) stock dividend
Nutriband last paid dividends on 01/01/1970. The next scheduled payment will be on 07/24/2019. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Last Split Factor:
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.